Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease

J Med Virol. 2003 Aug;70(4):537-44. doi: 10.1002/jmv.10428.

Abstract

Hepatitis B virus (HBV) mutants with deletions in the preS region have not been evaluated for association with viral genotypes. In a case-control study, HBV DNA samples collected from 80 each of carriers infected with HBV genotype B or C were examined for preS deletions. PreS deletion mutants were found in a total of 37 of 160 (23%) HBV carriers. Carriers with preS deletion mutants were older (56.0 +/- 12.7 vs 49.3 +/- 16.9 years, P < 0.05), were infected more frequently with HBV genotype C (84% vs 40%, P < 0.05), and had more advanced disease, such as liver cirrhosis and hepatocellular carcinoma (54% vs 31%; P < 0.05), than did those without such mutants. In a multivariate analysis, genotype C (odds ratio [OR] = 9.3, P < 0.001) and advanced liver disease (OR = 3.1, P < 0.01) were the most significant variables in association with preS deletions. A direct repeat sequence (TCAGG) was found at the start or at the end of preS1 deletions in 6 of the 20 (30%) cases examined, and preS2 deletions in these cases were clustered over the 5'-terminal half of this region. These results indicate that the development of preS deletion mutants depends on HBV genotypes and that it may be associated with progressive liver disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Carcinoma, Hepatocellular / physiopathology
  • Carcinoma, Hepatocellular / virology
  • Case-Control Studies
  • Female
  • Gene Deletion*
  • Genotype
  • Hepatitis B Surface Antigens / genetics*
  • Hepatitis B virus / classification*
  • Hepatitis B virus / genetics*
  • Hepatitis B, Chronic / physiopathology*
  • Hepatitis B, Chronic / virology
  • Humans
  • Liver Cirrhosis / physiopathology
  • Liver Cirrhosis / virology
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Protein Precursors / genetics*

Substances

  • Hepatitis B Surface Antigens
  • Protein Precursors